Primary aldosteronism (PA) is the most common etiology of endocrine hypertension (HTN),
and recent prevalence studies suggest that it may be under-diagnosed. Indications for …

Background To assess whether angiotensin-II receptor blockers (ARBs) offer any additional
advantage in confirming the diagnosis of primary aldosteronism (PA) and their use in the …

Primary aldosteronism is the most common form of secondary hypertension and patients
with hyperaldosteronism are more prone to premature cardiovascular complications …

Prospective evaluation of the saline infusion test for exclu... : Journal of Hypertension Prospective
evaluation of the saline infusion test for excluding primary aldosteronism due to …

Background: Despite being widely recognized as the most common form of secondary
hypertension, among the general hypertensive population the true prevalence of primary …

Primary aldosteronism (PA) is one of the most common causes of secondary hypertension. It
is usually caused by idiopathic adrenal hyperplasia or aldosterone-producing adenomas …

This retrospective review examined all primary aldosteronism (PA) adrenal vein sampling
(AVS), diagnoses, and outcomes from an endocrine hypertension unit where confirmatory …

The worldwide prevalence of primary aldosteronism (PA) among unselected patients with
hypertension is considered to be 10–15%(1, 2). However, there have always been wide …

Primary aldosteronism (PA) is associated with higher cardiovascular morbidity and mortality
rates than essential hypertension. The Japan Endocrine Society (JES) has developed an …

Rossi et al.[1] have recently shown that high-dose adrenocorticotrophic hormone (ACTH)-
testing does not improve the diagnostic accuracy of adrenal vein sampling (AVS). As they …